Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.
People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for ‘leaky gut’, according to new study. These changes in the gut could ...
Dr. Hernandez was named chief medical officer for GI management services group Gastro Health in January. Dr. Hernandez, a founding member of Gastro Health, will oversee clinical operations across all ...
Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential ...